GW&K Investment Management LLC Reduces Stake in National Health Investors, Inc. $NHI

GW&K Investment Management LLC lessened its position in National Health Investors, Inc. (NYSE:NHI) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 286,377 shares of the real estate investment trust’s stock after selling 8,733 shares during the quarter. GW&K Investment Management LLC’s holdings in National Health Investors were worth $22,767,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. JPMorgan Chase & Co. raised its position in National Health Investors by 305.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock valued at $84,389,000 after purchasing an additional 906,479 shares in the last quarter. Norges Bank acquired a new stake in National Health Investors in the second quarter valued at approximately $49,775,000. M Holdings Securities Inc. acquired a new position in National Health Investors during the 2nd quarter valued at about $36,607,000. Balyasny Asset Management L.P. raised its position in shares of National Health Investors by 66.9% in the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after purchasing an additional 246,486 shares during the last quarter. Finally, Centersquare Investment Management LLC lifted its stake in shares of National Health Investors by 21.8% during the third quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock worth $78,443,000 after buying an additional 176,410 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Trading Down 0.9%

Shares of NHI opened at $84.15 on Friday. National Health Investors, Inc. has a one year low of $66.41 and a one year high of $91.38. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The company has a market capitalization of $4.07 billion, a P/E ratio of 27.86, a P/E/G ratio of 4.55 and a beta of 0.65. The stock has a 50-day moving average price of $82.43 and a 200 day moving average price of $79.01.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The firm had revenue of $105.82 million during the quarter, compared to analyst estimates of $95.12 million. During the same quarter last year, the business posted $1.24 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Sell-side analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be paid a dividend of $0.92 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 annualized dividend and a yield of 4.4%. National Health Investors’s dividend payout ratio (DPR) is 121.85%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a report on Monday, January 5th. National Bank Financial set a $85.00 price target on shares of National Health Investors in a research note on Tuesday, January 20th. Wells Fargo & Company increased their target price on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. Finally, Truist Financial boosted their price objective on National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Monday, December 15th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and an average price target of $85.57.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.